Updates are available Correction dated 2022-08-23
Click to view Correction: https://doi.org/10.1038/s41467-022-32664-8
-
Authors
Lopaticki, Sash
McConville, Robyn
John, Alan http://orcid.org/0000-0002-6855-5470
Geoghegan, Niall http://orcid.org/0000-0001-9884-0769
Mohamed, Shihab Deen http://orcid.org/0000-0002-9920-1982
Verzier, Lisa
Steel, Ryan W. J. http://orcid.org/0000-0002-4802-2896
Evelyn, Cindy http://orcid.org/0000-0002-8818-0258
O’Neill, Matthew T. http://orcid.org/0000-0001-5185-8603
Soler, Niccolay Madiedo http://orcid.org/0000-0003-3689-9305
Scott, Nichollas E. http://orcid.org/0000-0003-2556-8316
Rogers, Kelly L. http://orcid.org/0000-0002-6755-0221
Goddard-Borger, Ethan D. http://orcid.org/0000-0002-8181-9733
Boddey, Justin A. http://orcid.org/0000-0001-7322-2040
-
Funding
Funding for this research was provided by:
Department of Education and Training | Australian Research Council (210100362)
Department of Health | National Health and Medical Research Council (GNT1123727, GNT1139546, 1176955)
- License Information
-
More Information
Article History
Received: 25 February 2022
Accepted: 7 July 2022
First Online: 29 July 2022
Change Date: 23 August 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-022-32664-8
Competing interests
: The authors declare no competing interests.
: All experimental protocols involving the HC-04 human hepatocyte cell line were reviewed and approved by the Walter and Eliza Hall Institute of Medical Research Biosafety Committee.
